Lithium Ion

Lithium Ion

SCHEMBL31706495

O=C([O-])c1cc(C2CCN(C3COC3)CC2)ccn1.O=C([O-])c1cc(C2CCN(C3COC3)CC2)ccn1.[Li+].[Li+]

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ TLR9 Q9NR96 6/20 0.43
▸ TLR8 Q9NR97 6/20 0.43
▸ TLR7 Q9NYK1 6/20 0.43
▸ MAP3K12 Q12852 10/20 0.41
▸ CSF1R P07333 1/20 0.37
▸ MAPK8 P45983 1/20 0.37
▸ MAPK9 P45984 1/20 0.37
▸ MAPK10 P53779 1/20 0.37
▸ OPRM1 P35372 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL31705410 1.00 TLR9 (0.43) TLR9TLR8TLR7MAP3K12CSF1R
Lithium Ion SCHEMBL31705021 0.93 MAP3K12 (0.39) TLR9TLR8TLR7MAP3K12CSF1R
SCHEMBL31706609 0.88 TLR9 (0.45) TLR9TLR8TLR7MAP3K12CSF1R
Lithium Ion SCHEMBL31704797 0.86 MAP3K12 (0.41) MAP3K12OPRM1
SCHEMBL31706475 0.84 TLR9 (0.47) TLR9TLR8TLR7MAP3K12CSF1R
Lithium Ion SCHEMBL31706750 0.83 TLR9 (0.43) TLR9TLR8TLR7
Lithium Ion SCHEMBL31706258 0.83 TLR9 (0.43) TLR9TLR8TLR7
Lithium Ion SCHEMBL21633065 0.81 LNPEP (0.37) CSF1R
SCHEMBL31705108 0.78 TLR9 (0.42) TLR9TLR8TLR7MAP3K12OPRM1
Lithium Ion SCHEMBL31706661 0.78 TLR9 (0.46) TLR9TLR8TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025215110-A1 NEW AMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS SOS1 INHIBITORS LES LABORATOIRES SERVIER (FR) 2025-10-16 — — WO disclosed
Send feedback